Expert Speakers

Andreas Stange

Vice President

TÜV SÜD

Bart Lubbers

Project Manager

European Scientific Foundation for Laboratory Hemato Oncology

Caoimhe Vallely-Gilroy

Head of Digital Health & Therapeutics

Merck Healthcare KGaA

Carl Barrett

Vice President, Oncology

AstraZeneca

Chris Bray

Head Global Regulatory Affairs, Precision Medicine and Companion Diagnostics

Merck KGaA

Christopher Peters

Clinical Senior Lecturer & Consultant Upper GI Surgeon

Imperial College London

Claudia Dollins

Executive Director, Regulatory Affairs, Companion Diagnostics & Precision Medicine

Bristol Myers Squibb

Dagmar Albers

Diversity & Inclusion Lead UK

Pfizer

Daniel Andersson

PhD

University of Gothenburg

Emanuela Oldoni

Scientific Programme Manager

European Infrastructure for Translational Medicine

Gregory Vladimir

Vice President, Translational Research

Exscientia

Helena Utkovic Westergren

Precision Medicine Lead & Director

AstraZeneca

Igor Rudychev

Vice President of Enterprise Analytics

Horizon Therapeutics

Iñaki Gutiérrez-Ibarluzea

Head

Osteba, Basque Office for HTA

Isabella Garshaw

Principal Clinical Biomarker Lead, Cardiometabolism

Boehringer Ingelheim

James Hewitt

Senior CDx Specialist

TÜV SÜD

Laura Benjamin

Chief Executive Officer

Oncxerna

Maria Orr

Head of Precision Medicine for Biopharmaceuticals

AstraZeneca

Michael Hubank

Director, Clinical Genomics Research

The Royal Marsden NHS

Michael Kagey

Senior Director of Translational Medicine

Leap Therapeutics

Mohini Rajasagi

Senior Director Translational Oncology & Clinical Biomarkers

MSD

Nathalie Pechoux

Global Oncology Marketing Director, Portfolio Companion Diagnostic Strategy

GlaxoSmithKline

Norbert Farkas

Founder & Managing Partner

Centivis AG

Patrick Fivey

Director of Precision Medicine Policy

AstraZeneca

Philipp Schatz

Regulatory Strategist IVD

Bayer

Randolf Kerschbaumer

Chief Executive Officer

OncoOne

Rob Slack

Vice President & Head of Pharmacology

Galecto

Sari Pesonen

Co-Founder & Chief Scientific Officer

Valo Therapeutics

Sir Mark Caulfield

Vice Principal (Health)

Queen Mary University of London

Stephanie Traub

Associate Director

UCB Pharma

Svetlana Mukhina

Associate Director, Global Regulatory Affairs, CDx

Merck KGaA

Thomas Hach

Executive Director

Novartis